NEW YORK (GenomeWeb) – Waters today reported that its revenues in the third quarter were up 2 percent year over year, with the strongest sales coming from the company's Asia-Pacific and academic and government customers.

The company posted revenues of $578 million, up from $565.6 million in Q3 2017, but falling short of the average Wall Street estimate of $587.8 million. Waters said that foreign currency translation decreased sales growth by around 1 percent in the quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

Dec
03
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.